Cannabis-induced psychosis associated with high potency “wax dabs”

https://doi.org/10.1016/j.schres.2016.01.056Get rights and content

Abstract

With mounting evidence that the risk of cannabis-induced psychosis may be related to both dose and potency of tetrahydrocannbinol (THC), increasing reports of psychosis associated with cannabinoids containing greater amounts of THC are anticipated. We report two cases of emergent psychosis after using a concentrated THC extract known as cannabis “wax,” “oil,” or “dabs” raising serious concerns about its psychotic liability. Although “dabbing” with cannabis wax is becoming increasingly popular in the US for both recreational and “medicinal” intentions, our cases raise serious concerns about its psychotic liability and highlight the importance of understanding this risk by physicians recommending cannabinoids for purported medicinal purposes.

Section snippets

Funding

The authors report no source of funding for this project.

Contributors

Joseph M. Pierre, M.D.

Michael Gandal, M.D., Ph.D.

Maya Son.

Conflicts of interest

The authors report no conflicts of interest in relation to this manuscript.

Acknowledgements

The authors report no acknowledgements in relation to this manuscript.

References (10)

There are more references available in the full text version of this article.

Cited by (63)

  • The chemistry and toxicology of vaping

    2021, Pharmacology and Therapeutics
View all citing articles on Scopus
View full text